Musculoskeletal Research Center, Velocity Physical Therapy, Santa Monica, California, USA
Medical Assessment Research Committee, Major League Soccer, New York, New York, USA.
J ISAKOS. 2021 May;6(3):170-181. doi: 10.1136/jisakos-2017-000145. Epub 2020 Nov 12.
Hamstring injuries (HSI) are the source of significant impairment and disability for both professional and recreational athletes. The incidence and prevalence of HSIs has been well documented in the literature, as they are among the most common soft tissue injuries reported. The significant time loss due to injury and the inherent risk of reinjury pose a significant issue to the athlete, their career longevity and the success of their respective team. This review will deal predominantly with describing the prevalence and incidence of HSI in athletes, discuss risk factors and the mechanisms of injury for HSI, how to properly diagnose, image and prognosticate appropriate return to sport (RTS) for individuals who have sustained an HSI, prescribe treatment and prevention strategies and to discuss relevant options to decrease overall risk of primary and secondary recurrence of HSI.Current treatments of acute HSI necessitate a thorough understanding of the mechanism of injury, identifying muscle imbalances and/or weakness, inclusion of eccentric and concentric hamstring (HS) and hip extension (HE) exercises, evaluation of pathokinematic movement patterns and use non-surgical methods to promote healing and RTS. This methodology can be used prospectively to mitigate the overall risk of HSI. Injection therapies for HSI, including ultrasound-guided platelet-rich plasma and corticosteroids, may impart some short-term benefit, but the existing literature is largely inconclusive with respect to long-term functional outcomes. Future directions should prioritise injury prevention, early diagnosis and targeted interventions that combine both non-surgical and minimally invasive orthobiological approaches and identifying biomechanical risk factors prospectively to mitigate risk.
腘绳肌损伤(HSI)是专业和业余运动员身体功能障碍和残疾的主要原因。在文献中,HSI 的发病率和患病率已有充分记录,因为它们是报告的最常见的软组织损伤之一。由于受伤导致的大量时间损失和再次受伤的固有风险,对运动员、他们的职业生涯寿命以及他们各自团队的成功构成了重大问题。本综述主要讨论 HSI 在运动员中的发病率和患病率,讨论 HSI 的危险因素和损伤机制,如何正确诊断、成像和预测发生 HSI 后的运动员重返运动(RTS)情况,制定治疗和预防策略,并讨论降低 HSI 原发性和继发性复发总体风险的相关选择。目前对急性 HSI 的治疗需要深入了解损伤机制,确定肌肉失衡和/或无力,包括离心和向心腘绳肌(HS)和髋关节伸展(HE)练习,评估运动病理模式,并使用非手术方法促进愈合和 RTS。这种方法可以前瞻性地用于降低 HSI 的总体风险。HSI 的注射治疗,包括超声引导下富血小板血浆和皮质类固醇,可能会带来一些短期益处,但现有文献在长期功能结果方面尚无定论。未来的方向应该优先考虑损伤预防、早期诊断和针对性干预,将非手术和微创的骨生物学方法结合起来,并前瞻性地确定生物力学危险因素,以降低风险。